anmelden
25 € WM-Startbonus auf dein Cash-Konto
BX Swiss TOP 30 CHF
1.473,09
PKT
-13,37
PKT
-0,90
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.10.10 | Novartis buy | Vontobel Research | |
| 20.10.10 | Kühne + Nagel International hold | Société Générale Group S.A. (SG) | |
| 20.10.10 | Kühne + Nagel International buy | ING | |
| 19.10.10 | Kühne + Nagel International buy | Vontobel Research | |
| 20.10.10 | UBS hold | UniCredit Research | |
| 20.10.10 | UBS buy | UniCredit Research | |
| 21.10.10 | Novartis buy | Banc of America Securities-Merrill Lynch | |
| 20.10.10 | Roche hold | Citigroup Corp. | |
| 18.10.10 | Roche kaufen | Hamburger Sparkasse AG (Haspa) | |
| 18.10.10 | Kühne + Nagel International buy | Vontobel Research | |
| 15.10.10 | Novartis buy | Société Générale Group S.A. (SG) | |
| 15.10.10 | Straumann hold | Vontobel Research | |
| 14.10.10 | Kühne + Nagel International hold | Société Générale Group S.A. (SG) | |
| 14.10.10 | Roche kaufen | Independent Research GmbH | |
| 14.10.10 | Sonova halten | Vontobel Research | |
| 13.10.10 | Novartis buy | Vontobel Research | |
| 13.10.10 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 12.10.10 | Novartis buy | Vontobel Research | |
| 13.10.10 | Novartis buy | Citigroup Corp. | |
| 12.10.10 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 12.10.10 | Nestlé buy | ING | |
| 11.10.10 | Givaudan hold | UniCredit Research | |
| 11.10.10 | Roche buy | Goldman Sachs Group Inc. | |
| 08.10.10 | Straumann hold | Vontobel Research | |
| 08.10.10 | Givaudan hold | Vontobel Research | |
| 11.10.10 | Novartis buy | SEB AG | |
| 07.10.10 | Zurich Insurance halten | Independent Research GmbH | |
| 07.10.10 | Roche kaufen | Hamburger Sparkasse AG (Haspa) | |
| 07.10.10 | Logitech buy | Vontobel Research | |
| 07.10.10 | Novartis buy | Vontobel Research | |
| 07.10.10 | Zurich Insurance buy | Vontobel Research | |
| 07.10.10 | Novartis buy | UBS AG | |
| 05.10.10 | UBS buy | Vontobel Research | |
| 05.10.10 | Novartis buy | Vontobel Research | |
| 06.10.10 | UBS kaufen | Independent Research GmbH | |
| 04.10.10 | Novartis neutral | UBS AG | |
| 01.10.10 | UBS kaufen | Independent Research GmbH | |
| 01.10.10 | Givaudan hold | Vontobel Research | |
| 01.10.10 | UBS buy | Vontobel Research | |
| 01.10.10 | Holcim overweight | HSBC |